What is Protagonist Therapeutics's net change in cash?

Protagonist Therapeutics (PTGX) reported net change in cash of $65.32M in Q1 2026.

How has Protagonist Therapeutics's net change in cash changed year-over-year?

Protagonist Therapeutics's net change in cash increased by 54.0% year-over-year, from $42.4M to $65.32M.

What does net change in cash mean?

Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.

Protagonist Therapeutics PTGX Net Change in Cash

Net Change in Cash at other companies

Bristol-Myers SquibbBMY

-$635M-220%

Eli LillyLLY

-$1.99B-1,035%

AmgenAMGN

$2.91B+192%

IncyteINCY

$363.28M+43.1%

AbbVieABBV

$4.16B+1,293%

Apogee Therapeutics, Inc.APGE

——

Other financials

Income statement

See full

Revenue$56.4M+99.0%

Operating income-$3.6M+81.1%

Net income$3.8M+132%

EPS (diluted)$0.05+126%

Balance sheet

See full

Cash & equivalents$193.7M+38.7%

Total debt$9.8M-13.9%

Total equity$655.5M-4.9%

Total assets$697.5M-6.0%

Cash flow

See full

Operating cash flow-$48.9M-139%

CapEx$215.0K-60.6%

Free cash flow-$49.2M-139%

Valuation

See full

Market cap$7.26B+127%

Enterprise value$7.07B+130%

P/S98×+82.6×

Profitability

See full

Operating margin-192.4%-205pp

Net margin-154.9%-182pp

FCF margin-12,264.3%-12,527pp

Returns & leverage

See full

Return on equity-17.1%-26.1pp

Debt / equity0×0.0×

Current ratio17.8×+0.5×

Where this comes from

Reported directly by Protagonist Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.

The official record: Protagonist Therapeutics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Protagonist Therapeutics's net change in cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Protagonist Therapeutics's net change in cash?: Protagonist Therapeutics (PTGX) reported net change in cash of $65.32M in Q1 2026.
How has Protagonist Therapeutics's net change in cash changed year-over-year?: Protagonist Therapeutics's net change in cash increased by 54.0% year-over-year, from $42.4M to $65.32M.
What does net change in cash mean?: Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.